AIDS defining events and mean CD4+ lymphocyte count at disease occurrence, in the two considered time periods
| Years 1985-95 (144 patients, 151 diseases) | Years 1997-9 (72 patients, 76 diseases) | |||
|---|---|---|---|---|
| AIDS defining diseases | No of diseases(%) | Mean CD4+ count (cells ×106/l (SD)) | No of diseases (%) | Means CD4+ count (cells ×106/l (SD)) |
| Pneumocystis carinii pneumonia | 40 (26.5) | 58.6 (49.0) | 22 (28.9) | 62.4 (72.1) |
| Oesophageal candidiasis | 21 (13.9) | 71. (62.6) | 16 (21.0) | 129.9 (98.1) |
| Neurotoxoplasmosis | 17 (11.3) | 79.9 (62.1) | 9 (11.8) | 75.6 (39.2) |
| Kaposi's sarcoma | 15 (9.9) | 98.1 (101.3) | 7 (9.2) | 133.3(68.3) |
| Cytomegalovirus (retinitis or disseminated disease) | 10 (6.6) | 77.3 (100.2) | 1 (1.3) | 48 |
| HIV encephalopathy (AIDS-dementia complex) | 7 (4.6) | 81.1 (45.9) | 2 (2.6) | 102.0 (29.7) |
| Extrapulmonary cryptococcosis | 6 (4.0) | 25.2 (19.4) | 0(—) | – |
| Disseminated mycobactoriosis | 5 (3.3) | 62.4 (50.5) | 1 (1.3) | 78 |
| Wasting syndrome | 5 (3.3) | 38.4 (41.1) | 5 (6.6) | 121.2 (54.0) |
| Non-Hodgkin's lymphoma or primary CNS lymphoma | 5 (3.3) | 116.3 (41.1) | 4 (5.3) | 125.9 (71.2) |
| Cryptosporidiosis | 4 (2.7) | 38.3 (10.2) | 0(—) | – |
| Tuberculosis (pulmonary or disseminated disease) | 3(2.0) | 148.2 (51.4) | 5 (6.6) | 289.3 (71.2) |
| Other AIDS defining events | 13 (8.6) | 55.3 (48.9) | 4 (5.3) | 73.3 (101.1) |